EXPERIMENTAL STUDY OF TOXIC PROPERTIES OF VMU-2012-05 DRUG - ORIGINAL NON-NUCLEESIDE INHIBITOR OF HIV-1 REVERSE TRANSCRIPTASE

• Main Authors: V. A. Vavilova (Author), E. V. Shekunova (Author), E. A. Jain (Korsakova) (Author), V. Yu. Balabanyan (Author), A. A. Ozerov (Author), M. N. Makarova (Author), V. G. Makarov (Author)
• Format: Book
• Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2021-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Antiretroviral therapy is currently the main component of treatment for HIV patients. The development of new, more effective and safer drugs is an urgent task.The aim of the research is to study the toxic properties of the finished dosage form (FDF) VMU-2012-05, a non-nucleoside reverse transcriptas...